Quality of pathology reports for advanced ovarian cancer: are we missing essential information? An audit of 479 pathology reports from the EORTC-GCG 55971/NCIC-CTG OV13 neoadjuvant trial

Leen Verleye; Petronella B Ottevanger; Gunnar B Kristensen; Tom Ehlen; Nick Johnson; Maria E L van der Burg; Nick S Reed; René H M Verheijen; Katja N Gaarenstroom; Berit Mosgaard; Jose Miguel Seoane; Jacobus van der Velden; Robert Lotocki; Winette van der Graaf; Björn Penninckx; Corneel Coens; Gavin Stuart; Ignace Vergote

doi:10.1016/j.ejca.2010.08.008

Quality of pathology reports for advanced ovarian cancer: are we missing essential information? An audit of 479 pathology reports from the EORTC-GCG 55971/NCIC-CTG OV13 neoadjuvant trial

Leen Verleye, Petronella B Ottevanger, Gunnar B Kristensen, Tom Ehlen, Nick Johnson, Maria E L van der Burg, Nick S Reed, René H M Verheijen, Katja N Gaarenstroom, Berit Mosgaard, Jose Miguel Seoane, Jacobus van der Velden, Robert Lotocki, Winette van der Graaf, Björn Penninckx, Corneel Coens, Gavin Stuart, Ignace Vergote

Obstetrics and Gynaecology

33 Citations (Scopus)

Abstract

To assess the quality of surgical pathology reports of advanced stage ovarian, fallopian tube and primary peritoneal cancer. This quality assurance project was performed within the EORTC-GCG 55971/NCIC-CTG OV13 study comparing primary debulking surgery followed by chemotherapy with neoadjuvant chemotherapy and interval debulking surgery.

Original language	English
Journal	European Journal of Cancer
Volume	47
Issue number	1
Pages (from-to)	57-64
Number of pages	8
ISSN	0959-8049
DOIs	https://doi.org/10.1016/j.ejca.2010.08.008
Publication status	Published - 2011

Keywords

Data Collection
Female
Health Facility Size
Humans
Medical Audit
Medical Records
Ovarian Neoplasms
Pathology, Clinical
Quality Assurance, Health Care

Access to Document

10.1016/j.ejca.2010.08.008

Cite this

Verleye, L., Ottevanger, P. B., Kristensen, G. B., Ehlen, T., Johnson, N., van der Burg, M. E. L., Reed, N. S., Verheijen, R. H. M., Gaarenstroom, K. N., Mosgaard, B., Seoane, J. M., van der Velden, J., Lotocki, R., van der Graaf, W., Penninckx, B., Coens, C., Stuart, G., & Vergote, I. (2011). Quality of pathology reports for advanced ovarian cancer: are we missing essential information? An audit of 479 pathology reports from the EORTC-GCG 55971/NCIC-CTG OV13 neoadjuvant trial. European Journal of Cancer, 47(1), 57-64. https://doi.org/10.1016/j.ejca.2010.08.008

Quality of pathology reports for advanced ovarian cancer: are we missing essential information? An audit of 479 pathology reports from the EORTC-GCG 55971/NCIC-CTG OV13 neoadjuvant trial. / Verleye, Leen; Ottevanger, Petronella B; Kristensen, Gunnar B et al.
In: European Journal of Cancer, Vol. 47, No. 1, 2011, p. 57-64.

Research output: Contribution to journal › Journal article › Research › peer-review

Verleye, L, Ottevanger, PB, Kristensen, GB, Ehlen, T, Johnson, N, van der Burg, MEL, Reed, NS, Verheijen, RHM, Gaarenstroom, KN, Mosgaard, B, Seoane, JM, van der Velden, J, Lotocki, R, van der Graaf, W, Penninckx, B, Coens, C, Stuart, G & Vergote, I 2011, 'Quality of pathology reports for advanced ovarian cancer: are we missing essential information? An audit of 479 pathology reports from the EORTC-GCG 55971/NCIC-CTG OV13 neoadjuvant trial', European Journal of Cancer, vol. 47, no. 1, pp. 57-64. https://doi.org/10.1016/j.ejca.2010.08.008

@article{86ed423eceb040a392e1057a14c0444c,

title = "Quality of pathology reports for advanced ovarian cancer: are we missing essential information? An audit of 479 pathology reports from the EORTC-GCG 55971/NCIC-CTG OV13 neoadjuvant trial",

abstract = "To assess the quality of surgical pathology reports of advanced stage ovarian, fallopian tube and primary peritoneal cancer. This quality assurance project was performed within the EORTC-GCG 55971/NCIC-CTG OV13 study comparing primary debulking surgery followed by chemotherapy with neoadjuvant chemotherapy and interval debulking surgery.",

keywords = "Data Collection, Female, Health Facility Size, Humans, Medical Audit, Medical Records, Ovarian Neoplasms, Pathology, Clinical, Quality Assurance, Health Care",

author = "Leen Verleye and Ottevanger, {Petronella B} and Kristensen, {Gunnar B} and Tom Ehlen and Nick Johnson and {van der Burg}, {Maria E L} and Reed, {Nick S} and Verheijen, {Ren{\'e} H M} and Gaarenstroom, {Katja N} and Berit Mosgaard and Seoane, {Jose Miguel} and {van der Velden}, Jacobus and Robert Lotocki and {van der Graaf}, Winette and Bj{\"o}rn Penninckx and Corneel Coens and Gavin Stuart and Ignace Vergote",

year = "2011",

doi = "10.1016/j.ejca.2010.08.008",

language = "English",

volume = "47",

pages = "57--64",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Limited",

number = "1",

}

TY - JOUR

T1 - Quality of pathology reports for advanced ovarian cancer

T2 - are we missing essential information? An audit of 479 pathology reports from the EORTC-GCG 55971/NCIC-CTG OV13 neoadjuvant trial

AU - Verleye, Leen

AU - Ottevanger, Petronella B

AU - Kristensen, Gunnar B

AU - Ehlen, Tom

AU - Johnson, Nick

AU - van der Burg, Maria E L

AU - Reed, Nick S

AU - Verheijen, René H M

AU - Gaarenstroom, Katja N

AU - Mosgaard, Berit

AU - Seoane, Jose Miguel

AU - van der Velden, Jacobus

AU - Lotocki, Robert

AU - van der Graaf, Winette

AU - Penninckx, Björn

AU - Coens, Corneel

AU - Stuart, Gavin

AU - Vergote, Ignace

PY - 2011

Y1 - 2011

N2 - To assess the quality of surgical pathology reports of advanced stage ovarian, fallopian tube and primary peritoneal cancer. This quality assurance project was performed within the EORTC-GCG 55971/NCIC-CTG OV13 study comparing primary debulking surgery followed by chemotherapy with neoadjuvant chemotherapy and interval debulking surgery.

AB - To assess the quality of surgical pathology reports of advanced stage ovarian, fallopian tube and primary peritoneal cancer. This quality assurance project was performed within the EORTC-GCG 55971/NCIC-CTG OV13 study comparing primary debulking surgery followed by chemotherapy with neoadjuvant chemotherapy and interval debulking surgery.

KW - Data Collection

KW - Female

KW - Health Facility Size

KW - Humans

KW - Medical Audit

KW - Medical Records

KW - Ovarian Neoplasms

KW - Pathology, Clinical

KW - Quality Assurance, Health Care

U2 - 10.1016/j.ejca.2010.08.008

DO - 10.1016/j.ejca.2010.08.008

M3 - Journal article

C2 - 20850296

SN - 0959-8049

VL - 47

SP - 57

EP - 64

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - 1

ER -

Quality of pathology reports for advanced ovarian cancer: are we missing essential information? An audit of 479 pathology reports from the EORTC-GCG 55971/NCIC-CTG OV13 neoadjuvant trial

Abstract

Keywords

Access to Document

Fingerprint

Cite this